Epigenetic Regulation of Phlpp1 in Cartilage Development and Regeneration
Epigenetic Regulation of Phlpp1 in Cartilage Development and Regeneration
批准号:
8893005
负责人:
Elizabeth W Bradley
金额:
$10.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-08-01 至 2019-07-31
关键词:
AffectAmericanAnimal ModelAnimalsArthritisBiological AssayBiologyCartilageCartilage DiseasesCell modelChondrocytesClinicCollagen Type IIContrast MediaCpG IslandsDNA MethylationDegenerative polyarthritisDeteriorationDevelopmentDisease ProgressionEconomic BurdenEnzyme Inhibitor DrugsEnzyme InhibitorsEpigenetic ProcessEpiphysial cartilageEquilibriumEventGene ExpressionGenetic ModelsGenetic TranscriptionGoalsHealthHistologyHistonesHumanImageImplantIn Situ HybridizationIn VitroInfectionJointsLearningLongevityMeasuresMedial meniscus structureMethylationMolecularMusOperative Surgical ProceduresPH DomainPainPain MeasurementPathogenesisPatientsPhenotypePhosphoric Monoester HydrolasesPhysiciansPrincipal InvestigatorProtein phosphataseProteoglycanReplacement ArthroplastyReportingResearchResearch PersonnelRiskRoleSignal PathwaySignal TransductionSurfaceSurgical ModelsTechniquesTestingTissuesTrainingTranscriptional RegulationVisitWorkX-Ray Computed Tomographyabstractingarticular cartilagecareercareer developmentcartilage degradationcartilage developmentcartilage regenerationcartilage repairdisabilityeffective therapyepigenetic regulationexperiencein vivoinhibitor/antagonistinnovationleucine-rich repeat proteinpost-doctoral trainingpreventprogramspromoterregenerativerepairedresearch studyskillssocialsuccesstherapeutic targettomographytraining project
中文摘要
摘要骨关节炎(OA)是美国老年人最常见的关节炎形式,也是导致残疾的主要原因。因此,OA给美国带来了巨大的社会和经济负担。骨性关节炎的进展是确定的,由于软骨再生能力有限,全关节置换术是骨性关节炎唯一有效的治疗方法。尽管减少疼痛和恢复活动能力的成功率很高,但关节植入物的寿命有限,手术存在许多风险,包括感染。因此,需要新的策略来促进关节软骨修复和/或减缓关节软骨退变和疾病进展。这项为期五年的职业发展申请的目标是建立一个研究项目,探索蛋白磷酸酶Phlpp1在骨关节炎疾病(OA)进展中的作用,并探索OA中控制Phlpp1转录的表观遗传机制。迄今为止,申请人的研究经验主要集中在不能概括OA表型的细胞和遗传模型上。本申请中提出的研究将进一步提高研究者的资格,提供骨关节炎手术模型的培训,并通过疼痛的功能评估、通过微计算机断层扫描(EPIC-microCT)离子造影剂的平衡分配、组织学评分和基因表达的表观遗传/转录控制来表征骨关节炎模型。该培训将提供详细描述表观遗传因素调节OA进展能力的机制研究所需的综合技能。该项目的完成和在梅奥诊所接受的培训将使首席研究员成为骨关节炎相关研究领域的主要贡献者。
英文摘要
DESCRIPTION (provided by applicant): Abstract Osteoarthritis (OA) is the most common form of arthritis and a leading cause of disability in older Americans; thus, OA poses an enormous social and economic burden in the US. OA progression is certain and since cartilage has limited regenerative capacity, total joint replacement is the only effective treatment for OA. Despite the high success rates of reducing pain and restoring mobility, joint implants have limited lifespans and surgeries present many risks, including infections. Thus, new strategies to promote articular cartilage repair and/or slow articular cartilage degeneration and disease progression are needed. The goal of this five year career development application is to establish a research program exploring the role of the protein phosphatase Phlpp1 in osteoarthritis disease (OA) progression and to explore the epigenetic mechanisms that control Phlpp1 transcription in OA. To date, the applicant's research experience focused mainly on cellular and genetic models that do not recapitulate the OA phenotype. The proposed research in this application will further advance the investigator's qualifications by providing training in surgical models of osteoarthriti and their characterization through functional assessments of pain, equilibrium partitioning of an ionic contrast agent via microcomputed tomography (EPIC-microCT), histological scoring and epigenetic/transcriptional control of gene expression. This training will provide a comprehensive skill set required for mechanistic studies detailing the ability of epigenetic factors to modulate OA progression. The completion of this project and the training received at the Mayo Clinic will prepare the Principal Investigator to be a leading contributor to the field of osteoarthritis-relatd research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
-
批准号:10001986
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2017
-
负责人:Elizabeth W Bradley
-
依托单位:
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
-
批准号:10237904
-
项目类别:
-
资助金额:$30.91万
-
财政年份:2017
-
负责人:Elizabeth W Bradley
-
依托单位:
Functions of the PH-Domain Leucine Rich Protein Phosphatase (Phlpp)1 in Osteoclasts
-
批准号:9761459
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2017
-
负责人:Elizabeth W Bradley
-
依托单位:
Runx2 and Axin2 Interactions During Bone Formation
-
批准号:8334718
-
项目类别:
-
资助金额:$5.57万
-
财政年份:2011
-
负责人:Elizabeth W Bradley
-
依托单位:
Runx2 and Axin2 Interactions During Bone Formation
-
批准号:8195738
-
项目类别:
-
资助金额:$5.3万
-
财政年份:2011
-
负责人:Elizabeth W Bradley
-
依托单位:
海外基金